# reload+after+2024-01-20 02:35:36.713678
address1§Duke Street House
address2§50 Duke Street
city§London
zip§W1K 6JL
country§United Kingdom
phone§44 20 7290 1050
website§https://arixbioscience.com
industry§Biotechnology
industryKey§biotechnology
industryDisp§Biotechnology
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.
fullTimeEmployees§9
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Tom  Davidson', 'title': 'Finance Director', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Laura  Craig', 'title': 'Investor Relations Officer', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tassos  Konstantinou Ph.D.', 'title': 'Managing Director', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jade  Fletcher', 'title': 'Financial Controller', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Felix  Breyer Ph.D.', 'title': 'Associate', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Roy  Bartel-Taverner M.D.', 'title': 'Analyst', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.035
priceToSalesTrailing12Months§11.583686
currency§GBp
forwardEps§0.0
exchange§LSE
quoteType§EQUITY
shortName§ARIX BIOSCIENCE PLC ORD 0.001P
longName§Arix Bioscience plc
firstTradeDateEpochUtc§1487318400
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§72b50ef1-e361-3522-a5c6-96bbb99b0917
messageBoardId§finmb_326506476
targetHighPrice§115.0
targetLowPrice§115.0
targetMeanPrice§115.0
targetMedianPrice§115.0
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§71.42
grossMargins§1.0
ebitdaMargins§0.58921003
trailingPegRatio§None
